Literature DB >> 11246844

Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States).

J V Lacey1, M Frisch, L A Brinton, F M Abbas, W A Barnes, P E Gravitt, M D Greenberg, S M Greene, O C Hadjimichael, L McGowan, R Mortel, P E Schwartz, R J Zaino, A Hildesheim.   

Abstract

OBJECTIVES: Few studies of smoking and cervical carcinoma have addressed the rare cervical adenocarcinomas or used DNA-based tests to control for human papillomavirus (HPV) infection.
METHODS: This multicenter case-control study included 124 adenocarcinoma cases, 307 community controls (matched on age, race, and residence to adenocarcinoma cases), and 139 squamous carcinoma cases (matched on age, diagnosis date, clinic, and disease stage to adenocarcinoma cases). Participants completed risk-factor interviews and volunteered cervical samples for PCR-based HPV testing. Polychotomous logistic regression generated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for both histologic types.
RESULTS: Eighteen percent of adenocarcinoma cases, 43% of squamous carcinoma cases, and 22% of controls were current smokers. After control for HPV and other questionnaire data, adenocarcinomas were consistently inversely associated with smoking (e.g. current: OR = 0.6, 95% CI 0.3-1.1; > or = 1 pack per day: OR = 0.7, 95% CI 0.4-1.3), while squamous carcinomas were positively associated with smoking (e.g. current: OR = 1.6, 95% CI 0.9-2.9; > or = 1 pack per day: OR = 1.8, 95% CI 1.0-3.3). Results in analyses restricted to HPV-positive controls were similar.
CONCLUSION: Smoking has opposite associations with cervical adenocarcinomas and squamous carcinomas. Although both histologic types are caused by HPV and arise in the cervix, etiologic co-factors for these tumors may differ.

Entities:  

Mesh:

Year:  2001        PMID: 11246844     DOI: 10.1023/a:1008918310055

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  18 in total

Review 1.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 2.  Insulin, insulin resistance, obesity, and cancer.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

3.  Participation rates in cervical cancer screening: experience in rural Northern Greece.

Authors:  A Vakfari; M Gavana; S Giannakopoulos; E Smyrnakis; A Benos
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

4.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

5.  CD83 polymorphisms and cervical cancer risk.

Authors:  Kelly J Yu; Janet S Rader; Ingrid Borecki; Zhengyan Zhang; Allan Hildesheim
Journal:  Gynecol Oncol       Date:  2009-05-15       Impact factor: 5.482

6.  Association between smoking and size of anal warts in HIV-infected women.

Authors:  H N Luu; E S Amirian; R P Beasley; L Piller; W Chan; M E Scheurer
Journal:  Int J STD AIDS       Date:  2012-11       Impact factor: 1.359

7.  REV1 genetic variants associated with the risk of cervical carcinoma.

Authors:  Xiaohong He; Feng Ye; Jing Zhang; Qi Cheng; Jiajie Shen; Huaizeng Chen
Journal:  Eur J Epidemiol       Date:  2008-05-10       Impact factor: 8.082

8.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

9.  Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.

Authors:  Anil K Chaturvedi; Ruth A Kleinerman; Allan Hildesheim; Ethel S Gilbert; Hans Storm; Charles F Lynch; Per Hall; Froydis Langmark; Eero Pukkala; Magnus Kaijser; Michael Andersson; Sophie D Fossa; Heikki Joensuu; Lois B Travis; Eric A Engels
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

10.  Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013.

Authors:  Anne-Michelle Noone; Kathleen A Cronin; Sean F Altekruse; Nadia Howlader; Denise R Lewis; Valentina I Petkov; Lynne Penberthy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.